2nd Quarter - Report — ASCENSION HEALTH for ASCENSION HEALTH (2017)

Firm

ASCENSION HEALTH

Client

ASCENSION HEALTH

Income

—

Expenses

$248,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Drug pricing; 340B Drug Discount Program; American Health Care Act, HR 1628; Protecting Seniors Access to Medicare Act of 2017, S 260

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
LEE DUONG	—
MARK L. HAYES	—
PETER M LEIBOLD	—

Contacted: Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1628 (115th)

Health Issues HCR

Healthcare access, safety and quality. Healthcare reform-- American Health Care Act HR 1628; Better Care Reconciliation Act

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
LEE DUONG	—
MARK L. HAYES	—
PETER M LEIBOLD	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1628 (115th)

Pharmacy PHA

Drug pricing; Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES) FAIR Drug Pricing Act

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
LEE DUONG	—
MARK L. HAYES	—
PETER M LEIBOLD	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.